Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Glycyrrhizic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 5 0
Kaempferol Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021 3 0
Sar9, Met (O2)11-Substance P Potential treatment - theoretical effect Experimental Antiviral Jan/08/2021 1 0
Futalosine Potential treatment - theoretical effect Natural product Antiviral Jan/08/2021 1 0
Myricetin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021 5 0
Theaflavin Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020 2 0
Excel (.xslx) CSV (.csv)